Varlilumab (CDX-1127) 是一种首创的人 IgG1 抗CD27单克隆抗体。Varlilumab 具有抗肿瘤活性。
| 生物活性 | Varlilumab (CDX-1127) is a first-in-class humanIgG1anti-CD27monoclonal antibody. Varlilumab has an anti-tumor activity[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 中文名称 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com